Cas no 7327-66-4 (Hexane-1,3,5-triol)
Hexane-1,3,5-triol Chemical and Physical Properties
Names and Identifiers
-
- 1,3,5-Hexanetriol
- hexane-1,3,5-triol
- 1,3,5-n-Hexanetriol
- AKOS026676557
- NS00044608
- 7327-66-4
- F8880-2722
- 1,3,5-Hexatriol
- starbld0034399
- SCHEMBL285354
- DTXSID60274063
- EINECS 230-805-4
- Hexane-1,3,5-triol
-
- Inchi: 1S/C6H14O3/c1-5(8)4-6(9)2-3-7/h5-9H,2-4H2,1H3
- InChI Key: WJSATVJYSKVUGV-UHFFFAOYSA-N
- SMILES: OC(CCO)CC(C)O
Computed Properties
- Exact Mass: 134.09432
- Monoisotopic Mass: 134.094
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 3
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 9
- Rotatable Bond Count: 4
- Complexity: 65.3
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 2
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: -0.6
- Topological Polar Surface Area: 60.7?2
Experimental Properties
- Density: 1.11
- Boiling Point: 314.8°C at 760 mmHg
- Flash Point: 159.4°C
- Refractive Index: 1.48
- PSA: 60.69
Hexane-1,3,5-triol Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | H118700-125mg |
Hexane-1,3,5-triol |
7327-66-4 | 125mg |
$ 70.00 | 2022-06-04 | ||
| TRC | H118700-250mg |
Hexane-1,3,5-triol |
7327-66-4 | 250mg |
$ 115.00 | 2022-06-04 | ||
| TRC | H118700-625mg |
Hexane-1,3,5-triol |
7327-66-4 | 625mg |
$ 225.00 | 2022-06-04 | ||
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1840826-1g |
Hexane-1,3,5-triol |
7327-66-4 | 97% | 1g |
¥13993.00 | 2024-07-28 |
Hexane-1,3,5-triol Related Literature
-
Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
-
Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296
-
Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
-
R. M. Pemberton,J. P. Hart,T. T. Mottram Analyst, 2001,126, 1866-1871
-
Hailing Chen,Lu Yin,Meng Liu,Laibing Wang,Michiya Fujiki,Wei Zhang RSC Adv., 2019,9, 4849-4856
Additional information on Hexane-1,3,5-triol
Recent Advances in Hexane-1,3,5-triol (CAS: 7327-66-4) Research: Applications and Innovations in Chemical Biology and Medicine
Hexane-1,3,5-triol (CAS: 7327-66-4) is a polyhydroxy compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound, characterized by its three hydroxyl groups attached to a hexane backbone, exhibits unique physicochemical properties that make it a valuable intermediate in synthetic chemistry and drug development. Recent studies have explored its potential as a building block for bioactive molecules, its role in supramolecular chemistry, and its applications in drug delivery systems.
A 2023 study published in the Journal of Medicinal Chemistry highlighted the use of Hexane-1,3,5-triol as a scaffold for designing novel antimicrobial agents. Researchers synthesized a series of derivatives by functionalizing the hydroxyl groups, resulting in compounds with enhanced activity against multidrug-resistant bacterial strains. The study emphasized the compound's ability to disrupt bacterial cell membranes, offering a promising avenue for addressing antibiotic resistance. Molecular docking simulations further revealed its potential to interact with key bacterial enzymes, providing insights for future drug design.
In the realm of drug delivery, Hexane-1,3,5-triol has been investigated for its role in forming stable micelles and liposomes. A 2024 paper in Advanced Materials demonstrated its utility in creating pH-responsive nanocarriers for targeted cancer therapy. The triol's hydroxyl groups facilitated the incorporation of hydrophobic drugs, while its structural flexibility allowed for tunable release kinetics. In vivo studies showed improved tumor accumulation and reduced off-target effects, underscoring its potential as a biocompatible delivery platform.
Beyond biomedical applications, Hexane-1,3,5-triol has also been explored in materials science. A recent ACS Applied Materials & Interfaces publication reported its use as a crosslinking agent in biodegradable polymers. The compound's ability to form hydrogen bonds enhanced the mechanical properties of the resulting materials, making them suitable for tissue engineering and wound healing applications. This interdisciplinary approach highlights the compound's versatility and potential for commercialization.
Despite these advancements, challenges remain in optimizing the synthesis and scalability of Hexane-1,3,5-triol-based products. Future research directions include exploring its enantioselective synthesis, investigating its metabolic pathways, and expanding its applications in personalized medicine. Collaborative efforts between chemists, biologists, and clinicians will be crucial to unlocking its full potential in addressing unmet medical needs.